Search

Search Results

• PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics

  Xiaoqiang Zheng, Hongbing Rui, Ying Liu, Jinfeng Dong

  e2020073

  2020-11-02

  https://doi.org/10.4084/mjhid.2020.073

  711

  PDF: 66

  HTML: 126

• miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS

  Meiwan Cao, BaoLing Peng, WanFu Xu, PeiYu Chen, Huan Chen, LiPing Ye, Jing Xie, HongLi Wang, Lu Ren, LiYa Xiong, JingNan Zhu, XiangYe Xu, LanLan Geng, SiTang Gong

  e2023040

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.040

  682

  PDF: 798

  PDF Supp. Files: 69

  HTML: 172

• CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL

  Abdolreza Sotoodeh Jahromi, Mohammad Kargar, Farshid Kafilzadeh, Marzieh Jamalidoust, Maliheh Moradzadeh

  e2021049

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.049

  1189

  PDF: 452

  HTML: 129

• Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease

  Marco Marziali, Antonella Isgrò, Pietro Sodani, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Cristiano Gallucci, Cecilia Alfieri, Andrea Roveda, Gioia De Angelis, Luisa Cardarelli, Michela Ribersani, Marco Andreani, Guido Lucarelli

  e2014066

  2014-08-28

  https://doi.org/10.4084/mjhid.2014.066

  1583

  PDF: 871

  HTML: 1857

  Untitled: 181

  Untitled: 163

• REDUCTION OF INTRAMEDULLARY APOPTOSIS AFTER STEM CELL TRANSPLANTATION IN BLACK AFRICAN VARIANT OF PEDIATRIC SICKLE CELL ANEMIA.

  Antonella Isgrò, Pietro Sodani, Marco Marziali, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Cristiano Gallucci, Gioia De Angelis, Cecilia Alfieri, Michela Ribersani, Daniele Armiento, Andrea Roveda, Marco Andreani, Manuela Testi, Guido Lucarelli

  e2014054

  2014-07-06

  https://doi.org/10.4084/mjhid.2014.054

  2396

  PDF: 1083

  HTML: 2091

• THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

  Elvira Pelosi, Dr. Germana Castelli, Ugo Testa

  e2022080

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.080

  1384

  PDF: 1097

  HTML: 249

• NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL

  Dimitar Efremov, Adrian Wiestner, Luca Laurenti

  e2012067

  2012-10-09

  https://doi.org/10.4084/mjhid.2012.067

  2449

  PDF: 821

  HTML: 8792

  Efremov 1: 208

  Efremov 2: 170

• CIRCRNA CIRCEHBP1 REGULATES THE MATURATION OF MIR-129 TO INCREASE THE CHEMORESISTANCE OF CANCER CELLS TO ADRIAMYCIN IN ACUTE MYELOID LEUKAEMIA

  Hong Li, Kehong Bi, Saran Feng, Yan Wang, Chuansheng Zhu

  e2022062

  2022-08-27

  https://doi.org/10.4084/MJHID.2022.062

  579

  PDF: 464

  HTML: 173

• USP9X INCREASED TUMOR ANGIOGENESIS IN MANTLE CELL LYMPHOMA BY UPREGULATION OF CCND1- MEDIATED SOX11

  Gang Huang, Jianjun Liao, Mingli Wang, Yali Huang, Mingjie Tang, Yanyan Hao

  e2022048

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.048

  782

  PDF: 659

  HTML: 194

• ON THE VERSATILITY OF VON WILLEBRAND FACTOR

  Antoine Rauch, Peter Lenting

  e2013046

  2013-07-10

  https://doi.org/10.4084/mjhid.2013.046

  2746

  PDF: 1092

  HTML: 11207

• TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA

  Marta Muzio, Eleonora Fonte, Federico Caligaris-Cappio

  e2012055

  2012-08-09

  https://doi.org/10.4084/mjhid.2012.055

  2528

  PDF: 843

  HTML: 17447

  Fig1 Caligaris: 150

  Fig.2 Caliga: 180

• HHVs AND LYMPHOPROLIFERATIVE DISORDERS

  C Quadrelli, P Barozzi, G Riva, Mario Luppi

  e2011043

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.043

  1347

  PDF: 801

  HTML: 3104

• DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia

  Buket Altinok Gunes, Yalda Hekmatshoar, Tulin Ozkan, Sureyya Bozkurt, O.Sena Aydos, Yahya Buyukasik, Elifcan Aladag, Asuman Sunguroglu

  e2023008

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.008

  1252

  PDF: 1148

  HTML: 426

• TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH SINGLE-AGENT ARSENIC TRIOXIDE

  Vikram Mathews, Ezhilarasi Chendamarai, Biju George, Auro Viswabandya, Alok Srivastava

  e2011056

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.056

  3573

  PDF: 899

  HTML: 4430

• THROMBOTIC MICROANGIOPATHY IN HAEMATOPOIETIC CELL TRANSPLANTATION:AN UPDATE

  Evi Stavrou, Hillard Michael Lazarus

  e2010033

  2010-10-29

  https://doi.org/10.4084/mjhid.2010.033

  1538

  PDF: 1024

  HTML: 10428

• TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML

  Buket Altinok Gunes, Tulin OZKAN, Aynur Karadag Gurel, Semih Dalkilic, Nevin Belder, Zeynep Ozkeserli, Hilal Ozdag Sevgili, Meral Beksac, Nilgun Sayinalp, Abdullah Munci Yagci, Asuman Sunguroglu

  e2024058

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.058

  978

  PDF: 1096

  Suppl. Files: 554

  HTML: 73

• IMMUNOLOGY OF TUBERCULOSIS

  Federica Bozzano, Francesco Marras, Andrea De Maria

  e2014027

  2014-04-07

  https://doi.org/10.4084/mjhid.2014.027

  5155

  PDF: 1966

  HTML: 7253

  Untitled: 186

• APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA

  Tadeusz Robak

  e2010011

  2010-05-07

  https://doi.org/10.4084/mjhid.2010.011

  1629

  PDF: 628

  HTML: 2415

• ATRA induced Reactive Hemophagocytosis: A Case Report

  Monica Sharma, Sanjeev Kumar Sharma, Jasmita Dass, Seema Tyagi

  e2011034

  2011-09-08

  https://doi.org/10.4084/mjhid.2011.034

  1185

  PDF: 560

  HTML: 2843

  ATRA induced Reactive Hemophagocytosis: A Case Report: 181

• PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

  Michele Bibas

  e2024007

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.007

  3457

  PDF: 2356

  HTML: 1412

• CUPROPTOSIS: A REVIEW ON MECHANISMS, ROLE IN SOLID AND HEMATOLOGICAL TUMORS, AND ASSOCIATION WITH VIRAL INFECTIONS

  MAURIZIO MARTINI, Pietro Tralongo, Mariagiovanna Ballato, Vincenzo Fiorentino, Walter Giordano, Valeria zuccalà, Cristina Pizzimenti, Arianna Bakacs, Antonio Ieni, Giovanni Tuccari, Guido Fadda, Luigi Maria Larocca

  e2025052

  2025-06-29

  https://doi.org/10.4084/MJHID.2025.052

  1548

  PDF: 906

  HTML: 140

• MOLECULAR MECHANISM OF TRAF6 IN MALIGNANT PROLIFERATION OF HUMAN NK/T CELL LYMPHOMA CELL HANK1

  Yan Qi, Chengbo Xu, Zesong Chen, Jiawei Chen, Congjie Chen

  e2025074

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.074

  412

  PDF: 176

  html: 27

• IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS

  Efterpi Kostareli, Maria Gounari, Andreas Agathangelidis, Kostas Stamatopoulos

  e2012052

  2012-08-09

  https://doi.org/10.4084/mjhid.2012.052

  2992

  PDF: 845

  HTML: 7150

  Kost Fig1: 167

  Kost Fig 2: 159

  Kost Fig3: 155

  Kost Fig 4: 172

  Kost Fig5: 170

  Kost fig 6: 156

• POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE

  Daniela Capello, Gianluca Gaidano

  e2009018

  https://doi.org/10.4084/mjhid.2009.018

  1210

  PDF: 456

  HTML: 18546

  Figure 1: 154

  Figure 2: 138

  Figure 3: 156

  Figure 4: 188

  Figure 5: 158

• THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition

  Emiliano Fabiani, Dr. Falconi, Dr. Cristiano, Dr. Hajrullaj, Dr. Falconi, Prof. Leone, Prof. Voso

  e2023064

  2023-10-30

  https://doi.org/10.4084/MJHID.2023.064

  1265

  PDF: 783

  HTML: 116

• GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS

  Angela Stoddart, Megan E. McNerney, Elizabeth Bartom, Rachel Bergerson, David J. Young, Zhijian Qian, Jianghong Wang, Anthony A. Fernald, Elizabeth M. Davis, Richard A. Larson, Kevin P. White, Michelle M. Le Beau

  e2011019

  2011-05-16

  https://doi.org/10.4084/mjhid.2011.019

  2532

  PDF: 778

  HTML: 5178

• RECENT ADVANCES IN THE 5Q- SYNDROME

  Andrea Pellagatti, Jacqueline Boultwood

  e2015037

  2015-05-20

  https://doi.org/10.4084/mjhid.2015.037

  2705

  PDF: 1762

  HTML: 3638

  Pellagatti Fig 1: 193

  Pellagatti Fig. 2: 192

• PATHOBIOLOGY OF HODGKIN LYMPHOMA

  Claudio Agostinelli, Stefano Pileri

  e2014040

  2014-06-05

  https://doi.org/10.4084/mjhid.2014.040

  3127

  PDF: 1383

  HTML: 5832

  Fig1-Ag-Pil: 205

  Ag-Pil Fig.2: 214

• SEPSIS-ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION AND THROMBOEMBOLIC DISEASE

  Nicola Semeraro, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci

  e2010024

  2010-08-06

  https://doi.org/10.4084/mjhid.2010.024

  3203

  PDF: 1606

  HTML: 4424

• EBV AND HIV-RELATED LYMPHOMA

  Michele Bibas, Andrea Antinori

  e2009032

  2009-12-29

  https://doi.org/10.4084/mjhid.2009.032

  1474

  PDF: 613

  HTML: 6794

• SYSTEMIC MASTOCYTOSIS: MOLECULAR LANDSCAPE AND IMPLICATIONS FOR TREATMENT

  Cecilia Monaldi, Sara De Santis, Manuela Mancini, Samantha Bruno, Michele Cavo, Simona Soverini

  e2021046

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.046

  1339

  PDF: 598

  HTML: 227

• Immune Biomarker Signature in the Diagnostic Workup of Fever Without Source: A Pilot Study

  Angela Maria Di Francesco, Giuliana Pasciuto, Laura Gerardino, Ludovico Luca Sicignano, Elena Verrecchia, Andrea Urbani, Donato Rigante, Raffaele Manna

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.030

  414

  PDF: 271

  HTML: 84

• Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF

  Wen Yao, Xinchen Fang, Peng Jiang, Juan Tong, Liangquan Geng, Xiaoyu Zhu, Baolin Tang, Xiang Wan, Kaidi Song, Lei Zhang, Ping Qiang, Guangyu Sun, Yongsheng Han, Huilan Liu, Zimin Sun

  e2022025

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.025

  1714

  PDF: 547

  HTML: 264

• “IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”

  Sara Martinelli, Antonio Cuneo, Gian Matteo Rigolin

  e2016047

  2016-10-15

  https://doi.org/10.4084/mjhid.2016.047

  3966

  PDF: 1014

  HTML: 3558

  Untitled: 165

  Cneo. Fig.1: 100

  Untitled: 89

  Untitled: 113

  Untitled: 116

• EBV IN HODGKIN LYMPHOMA

  Giuseppina Massini, Doerte Siemer, Stefan Hohaus

  e2009013

  https://doi.org/10.4084/mjhid.2009.013

  1607

  PDF: 577

  HTML: 13913

• ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY

  Irene Motta, Valentina Brancaleoni, Isabella Nava, Paola Delbini, Lorena Duca

  e2020075

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.075

  1450

  PDF: 1373

  HTML: 471

• MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA

  Melanie Joannides, Ashley N Mays, Anita R Mistry, Syed Khizer Hasan, Andreas Reiter, Joseph L Wiemels, Carolyn A Felix, Francesco Lo-Coco, Neil Osheroff, Ellen Solomon, David Grimwade

  e2011045

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.045

  2760

  PDF: 828

  HTML: 6502

  Untitled: 211

  Untitled: 172

  Untitled: 177

  Untitled: 196

• NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES

  Francesco D'Alò, Mariangela Greco, Marianna Criscuolo, Maria Teresa Voso

  e2010021

  2010-08-11

  https://doi.org/10.4084/mjhid.2010.021

  1884

  PDF: 711

  HTML: 681

• ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

  Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante

  e2022008

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.008

  1875

  PDF: 1066

  HTML: 577

• TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo

  e2025039

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.039

  1961

  PDF: 1387

  HTML: 248

• IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW

  Tomasz Sacha

  e2014007

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.007

  4585

  PDF: 2750

  HTML: 2250

• CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi

  e2022069

  2022-08-27

  https://doi.org/10.4084/MJHID.2022.069

  1902

  PDF: 844

  HTML: 1294

• NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2

  Mohsen Nakhaei, Zohreh-Al-Sadat Ghoreshi, Mohammad Rezaei Zadeh Rukerd, Hedyeh Askarpour, Nasir

  e2023059

  2023-10-16

  https://doi.org/10.4084/MJHID.2023.059

  878

  PDF: 438

  HTML: 102

• MICRORNA-181A-3P AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER FOR ACUTE MYELOID LEUKEMIA

  Xiaoling Ma

  e2020012

  2020-02-26

  https://doi.org/10.4084/mjhid.2020.012

  1615

  PDF: 1004

  HTML: 191

• Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India

  Mary Theresa Sylvia, Biswajit Dey, Debdatta Basu, Sajini Elizabeth Jacob, Rakhee Kar, Biswajit Dubashi

  e2016060

  2016-11-01

  https://doi.org/10.4084/mjhid.2016.060

  3136

  PDF: 750

  HTML: 2918

  Figure 1a and 1b: 136

  Figure 2: 142

  Figure 3: 164

  Figure 4: 143

  Figure 5: 148

  Tables 1-5: 141

• ACUTE PROMYELOCYTIC LEUKEMIA (APL): COMPARISON BETWEEN CHILDREN AND ADULTS

  Anna Maria Testi, Francesco Lococo

  e2014032

  2014-04-15

  https://doi.org/10.4084/mjhid.2014.032

  2686

  PDF: 1616

  HTML: 2249

• EXPRESSION OF OXIDATIVE STRESS AND INFLAMMATORY INDICATORS FOR CORONARY ARTERY DISEASE IN KAWASAKI DISEASE

  Haibo Zhang

  e2024052

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.052

  712

  PDF: 848

  HTML: 97

• TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi

  e2023038

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.038

  2004

  PDF: 1612

  HTML: 347

• Kikuchi-Fujimoto Disease in the United States: Three Case Reports and Review of the Literature

  Darcie M Deaver, Mojdeh Naghashpour, Lubomir Sokol

  e2014001

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.001

  1698

  PDF: 802

  HTML: 3582

• NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms

  Gianfranco Catalano, Pasquale Niscola, Cristina Banella, Daniela Diverio, Malgorzata Monika Trawinska , Stefano Fratoni, Rita Iazzoni, Paolo de Fabritiis, Elisabetta abruzzese, Nelida Ines Noguera

  e2020083

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.083

  1565

  PDF: 1141

  HTML: 184